Blackstone Makes $2.3 Billion Deal for Japan Drug Business

Blackstone Group is buying the consumer health-care business of Japan’s Takeda Pharmaceutical for $2.3 billion, one of the larger private-equity acquisitions in a country where such deals are slowly …
( read original story …)

---